ボツリヌス症市場レポート：2030年までの動向、予測、競合分析

ボツリヌス症の動向と予測

世界のボツリヌス症市場は、2024年から2030年にかけてCAGR 6.6％で成長すると予測されています。この市場の主な促進要因は、ボツリヌス症の発生率の上昇と医療技術分野の進歩です。ボツリヌス症の世界市場の将来は、小売薬局市場とオンラインショップ市場に機会があり、有望視されています。

ボツリヌス症のセグメント別市場

ボツリヌス症の世界市場について、毒素タイプ別、治療タイプ別、医薬品流通チャネル別、最終用途別、地域別の予測を掲載しています。

ボツリヌス症市場の洞察

Lucintel社の予測では、A型ボツリヌス製剤が予測期間中に高い成長を遂げる見込みです。

この市場の中では、処方薬やヘルスケア製品へのアクセスが広く普及していることから、小売薬局が引き続き大きなセグメントとなるでしょう。

北米は、この病気に対する認識が高まっており、高度な治療設備が容易に利用できることから、予測期間を通じて最大の地域であり続けるでしょう。

よくある質問

Q1.市場の成長予測は：

A1.世界のボツリヌス症市場は、2024年から2030年にかけてCAGR 6.6%で成長すると予測されています。

Q2.市場の成長に影響を与える主な促進要因は：

A2.この市場の主な促進要因は、ボツリヌス症の罹患率の上昇と医療技術分野の進歩です。

Q3.市場の主要セグメントは：

A3.ボツリヌス症市場の将来性は、小売薬局とオンラインストア市場での機会により有望視されています。

Q4.市場の主要企業は：

A4.ボツリヌス症の主要企業は以下の通りです：

• Allergan
• Pfizer
• AlphaVax
• Microbiotix
• Molecular Targeting Technologies
• Ipsen Technologies
• Galderma

Q5.今後、最大となる市場セグメントは：

A5.Lucintelは、A型ボツリヌス菌が予測期間中に高い成長を遂げると予測しています。

Q6.市場において、今後5年間に最大になると予想される地域は：

A6.北米はボツリヌス症に対する認識が高まっており、高度な治療施設が容易に利用できることから、予測期間中も最大の地域です。

Q7.レポートのカスタマイズは可能か：

A7.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界のボツリヌス症市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のボツリヌス症市場の動向（2018～2023年）と予測（2024～2030年）
• 毒素タイプ別ボツリヌス症の世界市場
  • ボツリヌス菌A型
  • ボツリヌス菌B型
• 治療タイプ別ボツリヌス症の世界市場
  • 抗毒素
  • 綿密な気道管理
  • 下剤
  • フォーリーカテーテル
  • その他
• 医薬品流通チャネル別ボツリヌス症の世界市場
  • 小売薬局
  • オンラインストア
• 最終用途別ボツリヌス症の世界市場
  • 病院・クリニック
  • その他

第4章 2018年から2030年までの地域別市場動向と予測分析

• 地域別ボツリヌス症の世界市場
• 北米のボツリヌス症市場
• 欧州のボツリヌス症市場
• アジア太平洋ボツリヌス症市場
• その他地域ボツリヌス症市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 毒素の種類別に見た世界のボツリヌス症市場の成長機会
  • 治療タイプ別の世界のボツリヌス症市場の成長機会
  • 医薬品流通チャネル別世界のボツリヌス症市場の成長機会
  • 最終用途別の世界のボツリヌス症市場の成長機会
  • 地域別の世界のボツリヌス症市場の成長機会
• 世界のボツリヌス症市場の新たな動向
• 戦略分析
  • 新製品の開発
  • 世界のボツリヌス症市場の能力拡大
  • 世界のボツリヌス症市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Allergan
• Pfizer
• AlphaVax
• Microbiotix
• Molecular Targeting Technologies
• Ipsen Technologies
• Galderma

Botulism Illness Trends and Forecast

The future of the global botulism illness market looks promising with opportunities in the retail pharmacy and online store markets. The global botulism illness market is expected to grow with a CAGR of 6.6% from 2024 to 2030. The major drivers for this market are rising incidence of botulism and progress in the field of medical technologies.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Botulism Illness by Segment

The study includes a forecast for the global botulism illness by toxin type, treatment type, drug distribution channel, end use, and region.

Botulism Illness Market by Toxin Type [Shipment Analysis by Value from 2018 to 2030]:

• Botulinum Type A
• Botulinum Type B

Botulism Illness Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:

• Antitoxins
• Meticulous Airway Management
• Cathartics
• Foley Catheter
• Others

Botulism Illness Market by Drug Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Retail Pharmacy
• Online Stores

Botulism Illness Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Others

Botulism Illness Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Botulism Illness Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies botulism illness companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the botulism illness companies profiled in this report include-

• Allergan
• Pfizer
• AlphaVax
• Microbiotix
• Molecular Targeting Technologies
• Ipsen Technologies
• Galderma

Botulism Illness Market Insights

Lucintel forecasts that botulinum type A is expected to witness higher growth over the forecast period.

Within this market, retail pharmacy will remain larger segment due to widespread accessibility for prescription medication and healthcare products.

North America will remain the largest region over the forecast period due to increasing awareness about the disease and easy availability of advanced treatment facilities in the region.

Features of the Global Botulism Illness Market

Market Size Estimates: Botulism illness market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Botulism illness market size by various segments, such as by toxin type, treatment type, drug distribution channel, end use, and region in terms of value ($B).

Regional Analysis: Botulism illness market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different toxin types, treatment types, drug distribution channels, end uses, and regions for the botulism illness market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the botulism illness market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for botulism illness market?

Answer: The global botulism illness market is expected to grow with a CAGR of 6.6% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the botulism illness market?

Answer: The major drivers for this market are rising incidence of botulism and progress in the field of medical technologies.

Q3. What are the major segments for botulism illness market?

Answer: The future of the botulism illness market looks promising with opportunities in the retail pharmacy and online store markets.

Q4. Who are the key botulism illness market companies?

Answer: Some of the key botulism illness companies are as follows:

• Allergan
• Pfizer
• AlphaVax
• Microbiotix
• Molecular Targeting Technologies
• Ipsen Technologies
• Galderma

Q5. Which botulism illness market segment will be the largest in future?

Answer: Lucintel forecasts that botulinum type A is expected to witness higher growth over the forecast period.

Q6. In botulism illness market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing awareness about the disease and easy availability of advanced treatment facilities in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the botulism illness market by toxin type (botulinum type A and botulinum type B), treatment type (antitoxins, meticulous airway management, cathartics, foley catheter, and others), drug distribution channel (retail pharmacy and online stores), end use (hospitals & clinics and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Botulism Illness Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Botulism Illness Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Botulism Illness Market by Toxin Type
  • 3.3.1: Botulinum Type A
  • 3.3.2: Botulinum Type B
• 3.4: Global Botulism Illness Market by Treatment Type
  • 3.4.1: Antitoxins
  • 3.4.2: Meticulous Airway Management
  • 3.4.3: Cathartics
  • 3.4.4: Foley catheter
  • 3.4.5: Others
• 3.5: Global Botulism Illness Market by Drug Distribution Channel
  • 3.5.1: Retail Pharmacy
  • 3.5.2: Online Stores
• 3.6: Global Botulism Illness Market by End Use
  • 3.6.1: Hospitals & Clinics
  • 3.6.2: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Botulism Illness Market by Region
• 4.2: North American Botulism Illness Market
  • 4.2.1: North American Botulism Illness Market by Toxin Type: Botulinum Type A and Botulinum Type B
  • 4.2.2: North American Botulism Illness Market by Drug Distribution Channel: Retail Pharmacy and Online Stores
• 4.3: European Botulism Illness Market
  • 4.3.1: European Botulism Illness Market by Toxin Type: Botulinum Type A and Botulinum Type B
  • 4.3.2: European Botulism Illness Market by Drug Distribution Channel: Retail Pharmacy and Online Stores
• 4.4: APAC Botulism Illness Market
  • 4.4.1: APAC Botulism Illness Market by Toxin Type: Botulinum Type A and Botulinum Type B
  • 4.4.2: APAC Botulism Illness Market by Drug Distribution Channel: Retail Pharmacy and Online Stores
• 4.5: ROW Botulism Illness Market
  • 4.5.1: ROW Botulism Illness Market by Toxin Type: Botulinum Type A and Botulinum Type B
  • 4.5.2: ROW Botulism Illness Market by Drug Distribution Channel: Retail Pharmacy and Online Stores

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Botulism Illness Market by Toxin Type
  • 6.1.2: Growth Opportunities for the Global Botulism Illness Market by Treatment Type
  • 6.1.3: Growth Opportunities for the Global Botulism Illness Market by Drug Distribution Channel
  • 6.1.4: Growth Opportunities for the Global Botulism Illness Market by End Use
  • 6.1.5: Growth Opportunities for the Global Botulism Illness Market by Region
• 6.2: Emerging Trends in the Global Botulism Illness Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Botulism Illness Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Botulism Illness Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Allergan
• 7.2: Pfizer
• 7.3: AlphaVax
• 7.4: Microbiotix
• 7.5: Molecular Targeting Technologies
• 7.6: Ipsen Technologies
• 7.7: Galderma